Survival Associations of Timely Postoperative Radiotherapy Among Head and Neck Cancer High-Risk Subgroups

被引:0
|
作者
Velez, Lisa M. Velez [1 ]
Corpuz, Timothy V. [1 ]
Schwetschenau, Luke C. [1 ]
Mazul, Angela [2 ]
Massa, Sean T. [1 ]
机构
[1] St Louis Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63103 USA
[2] Washington Univ, Sch Med St Louis, Dept Otolaryngol Head & Neck Surg, St Louis, MO USA
来源
LARYNGOSCOPE | 2025年
关键词
head and neck cancer; postoperative radiotherapy; survival; SQUAMOUS-CELL CARCINOMA; RADIATION-THERAPY; TREATMENT DELAYS; SURGERY; DISPARITIES; INITIATION; IMPACT; RACE;
D O I
10.1002/lary.32074
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
ObjectiveEffective implementation of timely postoperative radiation therapy (PORT) as a quality metric for head and neck squamous cell carcinoma (HNSCC) care may reduce survival disparities in subgroups with the highest risk of mortality-advanced stage and Black race. We sought to determine if the association between timely PORT and survival varies among clinical and demographic high-risk subgroups.MethodsIn this retrospective cohort study using the National Cancer Database 2004-2020, patients with HPV-negative HNSCC treated with surgery and PORT were identified. The association between PORT delay greater than 6 weeks with overall survival was assessed by Cox proportional hazards models with interaction effects for race, overall stage, and PORT delay.ResultsAmong 54,035 patients included in the study, 62% (33491) had PORT delays. Black patients were more likely to have PORT delays (aOR 1.19, 95% CI: 1.10-1.27). Timely PORT was only associated with improved survival for all stage I patients and White stage IV patients (predicted mortality risk 2.53, 95% CI: 2.34-2.74 versus 2.88, 95% CI: 2.67-3.09, referenced to White, stage I). After adjusting for covariates, timely PORT was estimated to be associated with inferior overall survival in Black patients with stage IV disease although with low precision (predicted mortality risk 3.24, 95% CI: 2.87-3.66, versus 2.71, 95% CI: 2.47-2.98, referenced to White, stage I).ConclusionTimely, guideline-adherent PORT may not reduce survival disparities in Black patients, especially those with advanced stage disease, suggesting other interventions are needed to address this disparity.Level of Evidence3.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Postoperative radiotherapy for high-risk head and neck squamous cell carcinoma
    Hamamoto, Y.
    Tsuruoka, S.
    Takata, N.
    Ishikawa, H.
    Nagasaki, K.
    Mochizuki, T.
    RADIOTHERAPY AND ONCOLOGY, 2019, 141 : S55 - S55
  • [2] miRNA associated with distal metastasis and local recurrence after postoperative radiotherapy in high-risk head and neck cancer
    Ding, Lianghao
    Karanam, Narasimha Kumar
    Yordy, John S.
    Giri, Uma
    Story, Michael D.
    CANCER RESEARCH, 2015, 75
  • [3] Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
    Cooper, JS
    Pajak, TF
    Forastiere, AA
    Jacobs, J
    Campbell, BH
    Saxman, SB
    Kish, JA
    Kim, HE
    Cmelak, AJ
    Rotman, M
    Machtay, M
    Ensley, JF
    Chao, KSC
    Schultz, CJ
    Lee, N
    Fu, KK
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19): : 1937 - 1944
  • [4] Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck
    Tanvetyanon, Tawee
    Padhya, Tapan
    McCaffrey, Judith
    Kish, Julie A.
    Deconti, Ronald C.
    Trotti, Andy
    Rao, Nikhil G.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (06): : 840 - 845
  • [5] HIGH-RISK HEAD AND NECK CANCERS TREATED WITH POSTOPERATIVE CONCURRENT RADIOTHERAPY AND CHEMOTHERAPY: IMPACT ON OUTCOMES
    Benavente, S.
    Ramos, M.
    Giralt, J.
    Urdambidelus, A.
    Hermosilla, E.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S255 - S256
  • [6] Refusal of postoperative radiotherapy and its association with survival in head and neck cancer
    Schwam, Zachary G.
    Husain, Zain
    Judson, Benjamin L.
    RADIOTHERAPY AND ONCOLOGY, 2015, 117 (02) : 343 - 350
  • [8] CARE PROCESSES LINKED TO TIMELY POSTOPERATIVE RADIOTHERAPY IN PATIENTS WITH HEAD, NECK CANCER, STUDY FINDS
    不详
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2019, 150 (01): : 8 - 8
  • [9] Postoperative chemoradiotherapy for high risk head and neck cancer
    Korda, N. Jovanovic
    Vucicevic, S.
    Jelic, S.
    Kreacic, M.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S70 - S70
  • [10] Randomized clinical trial on 7-days-a-week postoperative radiotherapy for high-risk squamous cell head and neck cancer
    Suwinski, Rafal
    Bankowska-Wozniak, Magdalena
    Majewski, Wojciech
    Idasiak, Adam
    Maciejewski, Adam
    Ziolkowska, Ewa
    Windorbska, Wieslawa
    Skladowski, Krzysztof
    Miszczyk, Leszek
    Maciejewski, Boguslaw
    RADIOTHERAPY AND ONCOLOGY, 2008, 87 (02) : 155 - 163